A message from Titanic

Journal of Practical Psychiatry and Behavioral Health

Volumn 4, Issue 4, 1998, Pages 236-242

  Preskorn, Sheldon H ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b University of Kansas School of Medicine Wichita Psychiatric Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004984054     PISSN: 10765417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Germain DM, Hughes PL, Follender AB: Potential fluoxetine-selegilene interaction. Ann Pharmacother 1992;26:1300.
2. Richard IH, Karlan R, Tanner C, et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinsons disease. Neurology 1997;48:1070-7.
3. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
4. Janicak P, Davis JM, Preskorn S, Ayd Jr F. Principles and practice of psychopharmacotherapy, 2nd Edition. Baltimore: Williams & Wilkins; 1997.
5. Preskorn S. Clinical pharmacology of selective serotonin reuptake inhibitors. Kaddo, OK: Professional Communications, Inc; 1996.
6. Preskorn S, Shad MU, Aldermon J, Lane R. Fluoxetine: Age and dose dependent pharmacokinetic and CYP 2D19 inhibition. Clin Pharm and Ther 1998;63(2):166.
7. Shad MU, Preskorn S. Antidepressants. In: Levy RH, Thummel K, Trager B, Hansten P, Eichelbaum M, eds. Metabolic drug interactions. Philadelphia: Lippincott Raven; in press.
8. Preskorn SH. What is the message in the alphabet soup of cytochrome P450 enzymes? J Pract Psychiatry Behav Health 1995;1:237-40.
9. Preskorn SH. I don't see 'em. J Pract Psychiatry Behav Health 1997;3:302-7.
10. Grace JM, Kinter MT, McDonald TL. Atypical metabolism of deprenyl and its enantiomer. (S)-(+)-N, alpha-dimethyl-N-propynylphenethy-lamine, by cytocrime P450 2D6. Chem Res Toxicol 1994;7:286-290.
11. Batty KT, Davis TM, Illett KF, Dusci LJ, Langton SR. The effect of ciprofloxacin on theophyline pharmacokinetics in healthy subjects. Br J Clin Pharm 1995;39(3):305-11.
12. Parker AC, Preston T, Heaf D, Kitteringham NR, Coonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Pharm 1994;38(6):573-6.
13. Preskorn S, Harvey A: Cytochrome P450 enzymes and psychopharmacology. In: Watson S, ed. Psychopharmacology: The fourth generation of progress [CD ROM version]. Philadelphia: Raven; in press.
14. Preskorn S. Reducing the risk of drug-drug interactions: A goal of rational drug development. J Clin Psychiatry 1996;57(suppl 1):3-6.